Cargando…

Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)

CONTEXT: Familial hypocalciuric hypercalcemia type 1 (FHH1) is caused by loss-of-function mutations of the calcium-sensing receptor (CaSR) and is considered a benign condition associated with mild-to-moderate hypercalcemia. However, the children of parents with FHH1 can develop a variety of disorder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dharmaraj, Poonam, Gorvin, Caroline M, Soni, Astha, Nelhans, Nick D, Olesen, Mie K, Boon, Hannah, Cranston, Treena, Thakker, Rajesh V, Hannan, Fadil M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096312/ https://www.ncbi.nlm.nih.gov/pubmed/32150253 http://dx.doi.org/10.1210/clinem/dgaa111

Ejemplares similares

SAT-404 Neonatal Hypocalcemic Seizures in Offspring of a Mother with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)
por: Hannan, Fadil M, et al.
Publicado: (2020)

Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss‐of‐Function Gα(11) Mutation
por: Gorvin, Caroline M, et al.
Publicado: (2017)

A G‐protein Subunit‐α11 Loss‐of‐Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2)
por: Gorvin, Caroline M, et al.
Publicado: (2016)

MON-539 Mice Harboring a Germline Heterozygous AP2S1 Mutation, Arg15Leu, Are a Model for Familial Hypocalciuric Hypercalcemia Type 3 (FHH3)
por: Hannan, Fadil, et al.
Publicado: (2019)

SAT-036 Extracellular Domain Calcium-Sensing Receptor (CaSR) Mutations Leading to Hypercalcemic and Hypocalcemic Disorders Cluster at the Homodimeric Interface
por: Olesen, Mie, et al.
Publicado: (2019)

Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
por: Nesbit, M. Andrew, et al.
Publicado: (2012)

Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy
por: Höppner, Jakob, et al.
Publicado: (2022)

Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population
por: Dershem, Ridge, et al.
Publicado: (2020)

Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects
por: Hannan, Fadil M., et al.
Publicado: (2015)

OR30-5 Germline Ablation of G-Protein Subunit Alpha-11 in Mice Causes Hypercalcemia That Is Rectified by Treatment with Cinacalcet
por: Hannan, Fadil, et al.
Publicado: (2019)

Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias
por: Gorvin, Caroline M, et al.
Publicado: (2018)

Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017)

Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism
por: Cranston, Treena, et al.
Publicado: (2022)

MON-258 Toddler with Hypercalcemia: Diagnosis of Familial Hypocalciuric Hypercalcemia
por: Kochanski, Justin, et al.
Publicado: (2019)

Severe Symptomatic Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia
por: Kurian, Roshini, et al.
Publicado: (2021)

Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls
por: Jones, Alicia R, et al.
Publicado: (2020)

A Case of Lithium-Associated Hypocalciuric Hypercalcemia
por: Nwabufor, Philip C, et al.
Publicado: (2020)

SAT-504 Role of Genetic Screening for FHH in a Patient with Hypercalcemia and Hyperparathyroidism
por: Caldwell, Laura, et al.
Publicado: (2019)

Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders
por: Babinsky, Valerie N., et al.
Publicado: (2016)

MON-532 Urinary Calcium Indices in Primary Hyperparathyroidism (PHPT) and Familial Hypocalciuric Hypercalcaemia (FHH): Is There a Need for Better Discrimination?
por: Arshad, Muhammad Fahad, et al.
Publicado: (2019)

Atypical Presentation of Familial Hypocalciuric Hypercalcemia: Case Report
por: Ali, Dalal S, et al.
Publicado: (2021)

Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology
por: Marx, Stephen J.
Publicado: (2017)

Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review
por: Zahedi, Maryam, et al.
Publicado: (2021)

Activating Mutations of the G-protein Subunit α (11) Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2
por: Gorvin, Caroline M, et al.
Publicado: (2019)

Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient
por: Wu, Bo, et al.
Publicado: (2017)

Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report
por: Sanada, Junpei, et al.
Publicado: (2021)

SUN-LB088 Octreotide Induced Hypocalcemia in Case of Familial Hypocalciuric Hypercalcemia
por: Alkhazaali, Ali, et al.
Publicado: (2019)

Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report
por: Marstrand, Simone Diedrichsen, et al.
Publicado: (2021)

Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia
por: Höppner, Jakob, et al.
Publicado: (2021)

Functional Assessment of Calcium-Sensing Receptor Variants Confirms Familial Hypocalciuric Hypercalcemia
por: Mullin, Benjamin H, et al.
Publicado: (2022)

Cinacalcet corrects hypercalcemia in mice with an inactivating Gα(11) mutation
por: Howles, Sarah A., et al.
Publicado: (2017)

Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
por: Rasmussen, Anne Qvist, et al.
Publicado: (2011)

Familial hypocalciuric hypercalcemia with a de novo heterozygous mutation of calcium-sensing receptor
por: Taki, Katsumi, et al.
Publicado: (2015)

Identification of a novel large CASR deletion in a patient with familial hypocalciuric hypercalcemia
por: García-Castaño, Alejandro, et al.
Publicado: (2018)

MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
por: Mudgal, Mayuri, et al.
Publicado: (2019)

SAT-361 Familial Hypocalciuric Hypercalcemia Type 3: AP2S1 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2020)

Clinical, Biochemical, and Genetic Profile of an Indian Kindred with Type 1 Familial Hypocalciuric Hypercalcemia
por: Alam, Sarah, et al.
Publicado: (2021)

A Novel Missense CASR Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia
por: Bletsis, Panagiotis, et al.
Publicado: (2022)

ODP128 Unusually High Serum Calcium in a Patient with Familial Hypocalciuric Hypercalcemia
por: Spiro, Andrew J, et al.
Publicado: (2022)

Intractable hypocalcemic seizures due to hypoparathyroidism
por: Midha, Naresh K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vi8ej7g8ch4vrrk3ace9j1in3j